150 related articles for article (PubMed ID: 25840688)
21. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer.
Han HS; Park YM; Hwang TS
J Gastroenterol Hepatol; 2006 Jul; 21(7):1108-14. PubMed ID: 16824061
[TBL] [Abstract][Full Text] [Related]
23. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
24. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
[TBL] [Abstract][Full Text] [Related]
25. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Oncol; 2002 May; 20(5):1041-7. PubMed ID: 11956602
[TBL] [Abstract][Full Text] [Related]
26. Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas.
Sierra A; Castellsague X; Escobedo A; Moreno A; Drudis T; Fabra A
Breast Cancer Res Treat; 1999 Mar; 54(1):39-45. PubMed ID: 10369079
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
28. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
[TBL] [Abstract][Full Text] [Related]
29. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
Bubb RS; Komaki R; Hachiya T; Milas I; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1216-24. PubMed ID: 12128123
[TBL] [Abstract][Full Text] [Related]
30. [Expression of apoptosis regulating proteins P 53, c-myc and bcl-2 on CD34+ hematopoietic cells isolated from human bone marrow].
Xi Y; Zhang S; Hao X
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):197-200. PubMed ID: 9596959
[TBL] [Abstract][Full Text] [Related]
31. DNA content in primary tumours and lymph node metastases in colorectal adenocarcinoma.
Koha M; Brismar B; Wikström B
APMIS; 1992 Jul; 100(7):640-4. PubMed ID: 1642852
[TBL] [Abstract][Full Text] [Related]
32. Evidence of clonal divergence in colorectal carcinoma.
Tollenaar RA; Bonsing BA; Kuipers-Dijkshoorn NJ; Hermans J; van de Velde CJ; Cornelisse CJ; Fleuren GJ
Cancer; 1997 Apr; 79(7):1304-14. PubMed ID: 9083151
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
[TBL] [Abstract][Full Text] [Related]
34. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
Song W; Liu MG; Zhang JB; Zhang JJ; Sun MM; Yu QK
Eur Rev Med Pharmacol Sci; 2016; 20(6):1093-7. PubMed ID: 27049262
[TBL] [Abstract][Full Text] [Related]
37. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
[TBL] [Abstract][Full Text] [Related]
38. Hydrostatic pressure induces apoptosis in human chondrocytes from osteoarthritic cartilage through up-regulation of tumor necrosis factor-alpha, inducible nitric oxide synthase, p53, c-myc, and bax-alpha, and suppression of bcl-2.
Islam N; Haqqi TM; Jepsen KJ; Kraay M; Welter JF; Goldberg VM; Malemud CJ
J Cell Biochem; 2002; 87(3):266-78. PubMed ID: 12397608
[TBL] [Abstract][Full Text] [Related]
39. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
Messick CA; Church JM; Liu X; Ting AH; Kalady MF
Ann Surg Oncol; 2010 Feb; 17(2):425-31. PubMed ID: 19885699
[TBL] [Abstract][Full Text] [Related]
40. [The protein expression of p53 and bcl-2 in laryngeal squamous cell carcinoma].
Liu S; Tang S; Lin Y; Liang C
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):191-3. PubMed ID: 12600081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
